Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

7.470 -2.150 (-22.35%)
Streaming Delayed Price Updated: 9:49 AM EDT, Sep 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,396,955
Open 7.390
Bid (Size) 7.430 (1)
Ask (Size) 7.460 (2)
Prev. Close 9.620
Today's Range 7.115 - 7.600
52wk Range 5.040 - 16.73
Shares Outstanding 98,983,261
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nasdaq Gains Over 100 Points; Dollar Tree Post Upbeat Earnings
 
Via Benzinga
Which stocks are moving before the opening bell on Wednesday?
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article. 
Via Chartmill

Performance

YTD
-43.9%
-43.9%
1 Month
-14.6%
-14.6%
3 Month
+14.9%
+14.9%
6 Month
-33.5%
-33.5%
1 Year
+34.6%
+34.6%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Earnings Scheduled For July 30, 2025
Via Benzinga
Insights into WAVE Life Sciences's Upcoming Earnings
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss WAVE Life Sciences Stock
Via Benzinga
Wave (WVE) Q2 Revenue Drops 56%
Via The Motley Fool
Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q2 2025 Earnings: Revenue Miss but Narrower Loss and Clinical Progress Boost Shares
Via Chartmill
Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
WAVE Life Sciences Earnings Preview
Via Benzinga
This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Breaking Down WAVE Life Sciences: 4 Analysts Share Their Views
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Where WAVE Life Sciences Stands With Analysts
Via Benzinga
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
The Analyst Verdict: WAVE Life Sciences In The Eyes Of 4 Experts
Via Benzinga
Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year
Via Benzinga

Frequently Asked Questions

Is Wave Life Sciences Ltd. - Ordinary Shares publicly traded?
Yes, Wave Life Sciences Ltd. - Ordinary Shares is publicly traded.
What exchange does Wave Life Sciences Ltd. - Ordinary Shares trade on?
Wave Life Sciences Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Wave Life Sciences Ltd. - Ordinary Shares?
The ticker symbol for Wave Life Sciences Ltd. - Ordinary Shares is WVE on the Nasdaq Stock Market
What is the current price of Wave Life Sciences Ltd. - Ordinary Shares?
The current price of Wave Life Sciences Ltd. - Ordinary Shares is 7.470
When was Wave Life Sciences Ltd. - Ordinary Shares last traded?
The last trade of Wave Life Sciences Ltd. - Ordinary Shares was at 09/03/25 09:49 AM ET
What is the market capitalization of Wave Life Sciences Ltd. - Ordinary Shares?
The market capitalization of Wave Life Sciences Ltd. - Ordinary Shares is 739.40M
How many shares of Wave Life Sciences Ltd. - Ordinary Shares are outstanding?
Wave Life Sciences Ltd. - Ordinary Shares has 739M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.